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Women Fare No Worse Than Men 10 Years After 
Attempted Coronary Angioplasty 
Peter N. Ruygrok, FRACP, Peter P.T. de Jaegere, MD, PhD, Ron T. van Domburg, MSC, 
Marcel J. van den Brand, MD, PhD, Patrick W. Serruys, MD, PhD, and Pim J. de Feyter, MD, PhD 
A retrospective review of cardiac events occurring in all patients who underwent at- 
tempted coronary angioplasty in the first 5 years of our experience (1980-1985) was 
undertaken. Follow-up data were obtained from the civil registry, hospltal records, pa- 
tient, family, and referring physician. Patient survival curves were constructed and the 
outcome of women and men was compared. Eight hundred fifty-six patients, 172 women 
and 684 men with a mean age of 60.0 and 55.3 years, respectively, underwent attempted 
coronary angioplasty with an overall procedural success rate of 82%, 77.7% in women 
and 83.1% In men. Follow-up data were obtained in 837 patients (97.8%) with a mean 
period of 9.6 years (range 0-13.3 years). 
The estimated 10 year survival in women was identical to men [79%, 95% confidence 
interval (CI) 72.6-85.4% vs. 78%, 95% CI 74.6-81.4%] as was the 10 year event-free sur- 
vival (men 36%, 95% CI 32.WO.O% vs. women 37%, 95% CI 29.2-44.8%), with a slmllar 
proportion of major cardiac events-death, myocardial infarction, coronary artery bypass 
surgery, and repeat angloplasty. When women were matched to men for age and previous 
myocardial infarction, factors found to be associated with an adverse outcome, there was 
no significant difference. Additionally, outcome was compared after patients were 
matched for maximum nominal balloon sire as an estimate of vessel size, with no sig- 
nificant difference between women and men. At follow-up, women complained of slgnlf- 
icantly more anginal symptoms than men (59.2% vs. 44.0%, P < 0.05) and took signifi- 
cantly more antianginal medication. 
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INTRODUCTION 
Despite major advances in the management of coro- 
nary artery disease, not only in surgical and interven- 
tional techniques but also in the identification and man- 
agement of coronary risk factors, it remains the leading 
cause of morbidity and mortality in both men and women 
in the Western world. A number of recent reports have 
focused on the possible inequities in the management of 
women with obstructive coronary artery disease particu- 
larly with regard to revascularization procedures [ 1-31, 
However, when considering the utilization of these tech- 
niques, one must take into account the relative risks and 
benefits of such procedures. It is important to recognize 
a difference in the demographic, clinical, and angio- 
graphic profile of women when compared with men. 
Women on average are older and have more cardiac risk 
factors than men and in addition generally have a higher 
prevalence of unstable angina and congestive heart fail- 
ure at the time of intervention. The in-hospital mortality 
after percutaneous transluminal coronary angioplasty 
(PTCA) increases with age and is higher in women than 
in men [4-61. 
The purpose of this study was to examine the long- 
term outcome following coronary angioplasty in women 
compared with men accepting the expected referral bias 
based on the above observations. 
SUBJECTS AND METHODS 
Patients 
Between September 1980 and December 1985, PTCA 
was attempted in 856 consecutive patients, 172 women 
and 684 men. Patient characteristics are displayed in Ta- 
ble I. The indication for angioplasty was stable angina in 
451 patients, unstable angina in 323, acute myocardial 
infarction in 76, and other indications in 6. All patients 
were treated with a combination of beta-blockers, cal- 
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TABLE 1. Characteristics of 856 Patients Who Underwent PTCA In 1980-1985 Divided 
Accordina to Gender’ 
Total Women Men P 
Number 856 172 684 
Age (years) 
Mean 56.3 60.0 55.3 <O.o001 
Range 22-80 41-78 22-80 
Indication for FTCA 
Stable angina 45 1 87 (50.6%) 364 (53.2%) 
Unstable angina 323 70 (40.7%) 253 (37.0%) 
MI 76 13 (7.6%) 63 (9.2%) 
Other 6 2 (0.1%) 4 (0.1%) NS 
Previous MI (%) 40 34.6 43.6 c0.05 
Previous CABG (%) 9.1 5.9 10 NS 
Number of vessels diseased (%) 
One 63.5 68.3 62.3 
Two 23.4 24.2 23.1 
Three 11.7 6.2 13.2 
Main stem 1.4 1.2 1.4 NS 
Ejection fraction <50% (%) 16.5 11.9 17.7 NS 
*MI, myocardial infarction; CABG, coronary artery bypass grafting; NS, non-significant. 
cium channel blockers, nitrates, and in unstable cases 
intravenous heparin. 
Angioplasty Technique 
At the commencement of the procedure 250 mg ace- 
tylsalicylic acid and 100 mg heparin were administered 
intravenously, with additional boluses of 50 mg given 
hourly. Following completion of the procedure, if the 
stability of the immediate result was in doubt, a heparin 
infusion was commenced to achieve an activated partial 
thromboplastin time of 2.0-2.5 times control for 12-24 
h. All patients continued to receive 40-60 mg nifedipine 
and 500 mg acetylsalicylic acid daily for a period of at 
least 6 months. The method of coronary angioplasty 
changed in February 1983 when the non-steerable cath- 
eter system originally described by Griientzig et al. [7] 
was replaced by steerable balloon systems [S]. During 
the study period the angioplasty balloons used were min- 
imally compliant, disposable, and inflated to 6-8 atmo- 
spheres in both men and women. Procedural clinical suc- 
cess was defined as a reduction in the luminal narrowing 
to less than 50% of the reference diameter, by visual 
assessment, with no major complications, namely, 
death, myocardial infarction, coronary artery bypass 
grafting, or repeat angioplasty, within 24 hr of the pro- 
cedure. Evidence of myocardial infarction immediately 
after the procedure was defined by a new Q wave andor 
elevation of myocardial enzymes to more than twice the 
upper limit of normal. 
Data Collection and Follow-Up 
Procedural details including maximum balloon size 
used and complications were recorded at the time of the 
procedure and entered into a dedicated data base. Proce- 
dure-related events were included in all follow-up anal- 
yses. All patients who survived hospital were initially 
checked against the civil registry to establish survival or 
death. This is a reliable and complete source of mortality 
data in The Netherlands. Primary endpoints considered 
at follow-up were death, non-fatal myocardial infarction, 
recurrent angina pectoris requiring coronary artery by- 
pass surgery, or repeat coronary angioplasty and event- 
free survival. These data were retrospectively obtained 
from the patient by letter or telephone, from family, or 
from the family doctor, and checked against hospital 
records. 
Assessment of late myocardial infarction in the fol- 
low-up period included a history of prolonged chest pain 
necessitating hospital admission and documentation of a 
myocardial infarction by electrocardiographic or enzyme 
criterion. Information on bypass surgery and repeat an- 
gioplasty was obtained from the patient and hospital data 
bases. Additionally, surviving patients were asked for 
information regarding symptoms of angina pectoris, 
graded according to the Canadian Cardiovascular Society 
classification [9], any resultant limitation in activities, 
and current medication. Follow-up data were obtained on 
all but 19 (2.2%) patients, the majority of whom had 
moved abroad. The period of follow-up ranged from 0 to 
13.3 years with a median of 9.6 years. 
Statistical Methods 
Differences between discrete variables were assessed 
with the chi-square test. Patient survival curves were 
constructed according to the method of Kaplan and 
Meier [lo]. P 5 0.05 was considered significant. 
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Fig. 1. Cumulative survival and event-free survival rates for 
men (solid lines) and women (broken lines) who underwent 
PTCA in 1980-1985 divided according to gender. Numbers are 
patients at risk and vertical lines indicate one standard error. 
MI, myocardial infarction; CABG, coronary artery bypass graft- 
ing. 
RESULTS year freedom from cardiac events 57%, 95% CI 53.4- 
In the years 1980-1985,969 consecutive PTCAs were 
performed on 856 patients. The procedural success rate 
was 82%, with 77.7% of women experiencing a suc- 
cessful angioplasty compared with 83.1 % of men [non- 
significant (NS)]. Three (1.7%) women suffered a 
procedural death compared with 5 (0.7%) men (NS). 
Long-term follow-up information was obtained on 837 
(97.8%) patients. 
Overall Survival and Events 
Six-hundred forty-one patients were alive (77%) and 
196 were deceased 8-14 years after their initial angio- 
plasty. One hundred forty-three (16.7%) patients had ex- 
perienced a myocardial infarction and 220 (25.7%) had 
undergone coronary artery bypass surgery, 62 (7.2%) as 
an emergency procedure immediately after coronary an- 
gioplasty. Two hundred twenty-one patients underwent 
further angioplasty in the follow-up period, 81 (9.5%) 
within 6 months of the initial procedure. 
Patient survival and event-free survival curves were 
calculated. The overall 5 and 10 year patient survivals 
were 90% [95% confidence interval (CI) 87.6-92.4%] 
and 78% (95% CI 75.0-81.0%), respectively, and the 
10 year survival with freedom from death, myocardial 
infarction, coronary artery bypass surgery, or repeat cor- 
onary angioplasty was 36% (95% CI 32.0-40.0%; 5 
60.6%). Long-term survival was significantly reduced in 
patients aged 1 6 0  years and in those with a history of 
previous myocardial infarction, multivessel disease, and 
impaired left ventricular function. 
Influence of Gender 
Women were significantly older than men at the time 
of initial angioplasty with a mean age of 60.0 compared 
with 55.3 years in men ( P  < 0.001). Additionally, 
women had suffered fewer myocardial infarctions than 
men prior to intervention, 34.6% and 43.6%, respec- 
tively (P < 0.05). There were no significant differences 
in the other clinical parameters. Patient survival and 
event-free survival curves were constructed (Fig. 1). 
Survival at 10 years was identical for women and men at 
79% (95% CI 72.6-85.4%) and 78% (95% CI 74.6- 
81.4%), respectively (5 year survival 91% women, 90% 
men), as was the incidence of clinical events at 36% 
(95% CI 32.0-40.0%) for men and 37% (95% CI 29.2- 
44.8%) for women with a similar proportion of myocar- 
dial infarctions, bypass operations, and repeat coronary 
angioplasty procedures in the follow-up period (Table 
11). The mean maximum balloon size used differed be- 
tween women and men with respective mean diameters 
of 2.90 and 3.04 mm (P < 0.0005) (Table 111). If we use 
maximum balloon size as an estimation of reference ves- 
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TABLE II. Major Cardiac Events Occurring in the Follow-Up 
Period Divided Accordina to Gender 
Women Men P 
Death 39 (23.5%) 157 (23.3%) NS 
Myocardial infarction 24 (14%) 119 (17.4%) NS 
CABG" 43 (25.0%) 177 (25.9%) NS 
Re-PTCA 43 (25.0%) 178 (26.0%) NS 
"CABG, coronary artery bypass grafting. 
sel size, assuming a reference vessel to balloon size ratio 
of 1: 1 ,  then women undergoing angioplasty in the study 
period had significantly smaller vessels than men. 
A question that arises from these findings is whether 
long-term outcome in women is in fact superior to a 
similar group of men when the negative influences on 
outcome are taken into account. We therefore matched 
172 women with 172 men for age (mean age women 
60.03 years, standard deviation 8.07 years vs. mean age 
men 60.01 years, standard deviation 8.09 years) and pre- 
vious myocardial infarction (both groups 55 previous in- 
farction, 104 no previous infarction, 13 unknown), fac- 
tors associated with an adverse outcome, which differed 
significantly between the two groups; there was no sig- 
nificant difference in 10 year survival (Fig. 2). When we 
matched 143 women with 143 men for balloon size and 
compared long-term outcome, there was again no signif- 
icant difference (P = 0.27) (Fig. 3). 
Details of symptomatic status and cardiac medication 
were obtained in 630 of the 648 survivors (98%). Angina 
class, the degree of limitation in 293 of 296 patients with 
angina, and the number of different antianginal medica- 
tions from the classes nitrate, beta-blocker, and calcium 
channel blocker are displayed in Table IV. Significantly 
more surviving women than men experienced angina 
with 59.2% and 44%, respectively, suffering anginal 
symptoms at the time of interview (P < 0.05). In these 
patients, there was a similar distribution between angina 
classes 1-111 and objective assessment of limitation in 
activities. Women also took significantly more antiangi- 
nal medication with 70% on at least one agent compared 
with 57% of men. 
DISCUSSION 
Women appear to delay the onset of clinically manifest 
coronary disease by 4-5 years when compared with 
men, which is most likely related to the premenopausal 
protective effect of estrogen [ 1 1,121, and one must ques- 
tion whether the older age at presentation results in lower 
referral and acceptance rates for coronary interventions, 
possibly explaining the much smaller proportion of 
women who undergo such procedures. Twenty percent 
of patients undergoing coronary angioplasty in our insti- 
tution in the years 1980-1985 were women and they 
TABLE 111. Maximum Nominal Balloon Size Used During 
Anaioolastv: ComDarlson of Women and Men 
Balloon size (mm) Women Men 
2.0 
2.5 
3.0 
3.5 
3.75 
24.0 
Mean* 
Standard deviation 
12 (7.6%) 
28 (17.8%) 
101 (64.3%) 
6 (3.8%) 
10 (6.4%) 
0- 
2.90 
0.40 
36 (5.6%) 
70 (10.9%) 
388 (60.5%) 
41 (6.4%) 
104 (16.2%) 
2 (0.3%) 
3.04 
0.44 
*P < 0.0005. 
were on average 4.7 years older (P  < O.OoOl), had suf- 
fered less myocardial infarction ( P  < O.OS) ,  undergone 
less prior coronary artery bypass surgery, had less 
chance of impaired left ventricular function, and were 
less likely to have multivessel disease than men over the 
same period, findings consistently reported by others 
(Table V). Additionally women undergoing angioplasty 
have been found to have a greater chance of having un- 
stable angina and an increased likelihood of an adverse 
risk factor profile at the time of intervention [6,13]. 
Overall 5 year survival was 90% (91% for women and 
90% for men) which, although favorable, appears to be 
at the lower limit of previously reported data, where 5 
year survival ranges from 89.2 to 96.3% [16-181. How- 
ever, one must recognize the variation in patient popu- 
lations; e.g., one may expect a better outcome following 
a successful angioplasty in a patient with stable angina 
and single vessel disease, where the prognosis is excel- 
lent even with medical therapy [19]. In our study, all 
patients in whom coronary angioplasty was attempted 
were included for analysis including those with angio- 
plasty for an acute myocardial infarction. We felt this 
population more closely resembles the cross-section of 
current angioplasty practice. Several studies have found 
that outcome in terms of survival and major cardiac 
events, up to 5 years following angioplasty, is similar in 
women and men once the higher rate of in-hospital 
events has been accounted for [4,6,13]. These observa- 
tions have been extended to the long-term by our study. 
Ten year survival was 79% for women and 78% for men 
and event-free survival was identical at 36%. When 
women and men were matched for age and a history of a 
previous myocardial infarction, factors found to be as- 
sociated with a significantly poorer long-term outcome in 
our study, no significant difference was found. One can 
suggest that a balance has been found between the fa- 
vorable and non-favorable clinical factors in the selection 
of women referred for interventional procedures such 
that their outcome in the long-term is the same as that for 
men. The only other study reporting 10 year survival is 
that of King and Schlumpf [20], who described the long- 
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Fig. 2. Cumulative survival and event-free survival rates for 172 women (broken lines) matched 
with 172 men (solid lines) from the same period for age and history of previous myocardial 
infarction (MI). CABG, coronary artery bypass grafting. Numbers and lines as in Figure 1. 
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Fig. 3. Cumulative survival and event-free survival rates for 143 women (broken lines) matched 
with 143 men (solid lines) for maximal nominal balloon size. MI, myocardial infarction; CABG, 
coronary artery bypass grafting. Numbers and lines as in Figure 1. 
term outcome of Grtientzig's first 169 coronary angio- 
plasty patients. In this group of relatively young, highly 
selected patients, 10 year survival was 89.5%. Although 
the study populations are not comparable, particularly 
with respect to the proportion of multivessel disease, it is 
of interest to note that the 10 year survival of the Coro- 
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TABLE IV. Symptomatic Status and Antianginal Medication of Surviving Patients 
Divided Accordina to Gender IN = 630) 
Women Men P 
Angina class 
0 51 (40.8%) 
I 16 (12.8%) 
TI 31 (24.8%) 
III 27 (21.6%) 
Iv 0 
No limitation 13.5 
Mild limitation 68.9 
Severe limitation 17.6 
None or aspirin 29.8 
Single therapya 33.1 
Double therapy 26.6 
Triple therapy 10.5 
Limitation in activities (symptomatic patients) (%) 
Antianginal medication (%) 
283 (56.0%) 
49 (9.7%) 
103 (20.4%) 
70 (13.9%) 
0 <0.05 
17.4 
67.1 
15.5 NS 
43.0 
30.9 
18.2 
7.9 <0.05 
aNitrate, beta-blocker, or calcium channel blocker. 
TABLE V. Comparison of Reported Baseline Characteristics of Women and Men Who Underwent Coronary Angioplasw 
Bell et al. [4] Kelsey et al. [6] Weintraub et al. [13] McEniery et al. [14] Arnold et al. [15] Present study 
Women Men Women Men Women Men Women Men Women Men Women Men 
Number 
Proportion 
Mean age (years) 
Unstable angina 
Previous MI 
Previous CABG 
MV disease 
EF <50% 
824 2,203 546 1,590 2,845 7,940 969 
27 73 25.6 74.4 26.3 73.7 26.2 
66 61 61 .O 56.5 62 57 61 
26 75.8 67.5 60.4 49.9 - - 
51.9 54.1 31.5 36.8 31.0 35.4 32 
9 
63.1 65.3 51.6 51.3 25.2 31.0 - 
- - 13.5 20.5 14.4 17.6 - 
- 8.7 14.7 9.9 12.6 - 
2,727 
73.8 
57 
16 
34 
15 
- 
- 
1,274 
25 
61.5 
58.6 
31.5 
10 
- 
9.2 
3,726 172 
75 20.1 
57.5 60.0 
47.8 40.6 
36 34.6 
14.6 5.9 
- 31.7 
11.8 11.9 
684 
79.9 
55.3 
37.0 
43.6 
10 
31.7 
17.7 
*Data are percentages except where indicated. MI, myocardial infarction; CABG, coronary artery bypass grafting; MV, multivessel; EF, ejection 
fraction. 
nary Artery Surgery Study (CASS) registry patients who 
were initially assigned surgical management was 70% 
for women and 73% for men [21]. 
The influence of vessel size on outcome has been of 
interest and is relevant when comparing the outcome of 
coronary angioplasty in men and women. The outcome 
of surgical revascularization in women who have a 
smaller body surface area has been reported to be less 
favorable than in men [22,23]. It has been found that 
adjusting for body surface area, a surrogate for coronary 
artery size [24], appears to remove the influence of gen- 
der on immediate outcome following coronary angio- 
plasty [15,25] and that a larger body surface area may 
confer a more favorable long-term outcome [ 131. As an 
estimation of coronary vessel size we used the nominal 
size of the largest angioplasty balloon used during an- 
gioplasty procedure. We believe the assumption of a 1:l 
ratio of maximal balloon size to reference vessel diam- 
eter, or at least a consistent ratio in men and women, to 
be a valid one, although making this assumption in the 
absence of data remains a limitation of our study. The 
maximum balloon size was significantly smaller in wo- 
men, thus suggesting smaller coronary arteries. When 
men and women were matched for this variable there was 
no significant difference in long-term outcome, although 
there was a trend toward improved event-free survival in 
women. The reasons are speculative but may be related 
to the superior cardiac status of women at the time of 
intervention as outlined above. Additionally, it has been 
suggested recently that atherosclerotic lesions in women 
are less likely to have calcium than lesions with a similar 
degree of luminal narrowing in men [26], the presence of 
calcium being a factor associated with a less favorable 
procedural result [27]. 
Our finding of significantly more angina in surviving 
women than in men (59% vs. 44%) is consistent with the 
findings of others, with women appearing to have a 20- 
40% increased chance of suffering anginal symptoms at 
follow-up than men [6,13,14]. Additionally, women in 
our study took significantly more antianginal medication 
(beta-blocker, calcium channel blocker, and/or nitrate) 
than men, an observation also previously reported [6, 
141. Thus, it appears that for a comparable risk of an 
adverse cardiac event in the long-term, women achieve 
less symptomatic relief than men. 
CONCLUSIONS 
Women selected to undergo PTCA are older, have 
more unstable angina, and on the whole have less com- 
plex cardiac disease than men. Their long-term prognosis 
following attempted coronary angioplasty is good and 
identical to that of men with respect to survival and in- 
cidence of major cardiac events. However, in the long- 
term, women are more likely to retain or have a recur- 
rence of anginal symptoms and more frequently require 
antianginal medication than men. 
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